颜崇超

上海恒瑞医药临床数据科学中心副总经理

颜崇超，DIA（中国）顾问委员会委员,中国临床数据管理学组（CDMC）成员，现任上海恒瑞临床数据科学中心副总经理。曾是辉瑞（中国）研发中心数据服务部的技术运营负责人，并在上海医药临床研究中心数据管理部任高级总监。先后在美国勃林格殷格翰从事临床研究数据管理工作，以及在意大利高级卫生研究院，美国亚利桑那大学医学院和纽约大学医学院从事医学研究。在国内外期刊上发表过40余篇学术论文。《医药临床研究中的数据管理》书作者，北京，科学出版社，2011。

郭旭光

方恩医药发展有限公司数据统计副总裁

毕业于白求恩医科大学，就职于中国预防医学科学院从事公共营养学研究。1988年应英国国家医学研究院 (Medical Research Council)邀请，他赴英国南安普顿大学从师于David Barker教授，开启”成人疾病胎儿起源”科学假设的验证研究。1992年获美国北卡罗莱纳大学公共卫生学院奖学金，赴美攻读营养流行病学博士，生物统计学硕士。博士毕业后20年来，先后受聘于美国北卡罗来纳大学临床统计中心，Constella, SRA International 和Westat研究公司，任统计分析员，高级研究员/高级统计师，资深学者，项目高级经理等职位，为美国联邦卫生研究机构NIH和CDC提供统计咨询，并参加NIEHS资助的多项临床医学研究(新生儿畸形，乳腺癌，老年痴呆，帕金森氏病等)和药物试验的统计工作，发表论文50余篇。2017年8月，加盟方恩医药发展有限公司美国团队，出任中国区生物统计及发展团队副总裁，负责全球临床实验的数据和统计研发管理及培训。

张若琳

北京百奥知信息科技有限公司临床数据副总裁

 Peking University, Master degree in Bio-statistics; Tongji Medical College of HUST, Bachelor degree in Preventive Medicine  15 years biometric experience  Rich experience in DM work of many multi-regional clinical trials  Rich experience in the management of EDC/paper projects conduction, IWRS/drug supply system, and third-party vendors including Central Lab, ePRO, ERT, Central Reading etc.  Served for Covance, Pfizer, and Chiltern as the DM lead  Speaker for DIA seminar and CFDA training course

Eric Forsthoffer

美国Bioclinica公司全球MIT及电子临床解决方案副总裁

Eric is a clinical trial project management professional with more than 15 years of clinical trial experience. He currently oversees Global Business Development for Bioclinica's industry-leading Medical Imaging & Biomarkers segment. Since joining the Company (formerly Bio-Imaging Technologies, Inc.) in April 2002, as a Site Administration Associate, Eric has held numerous positions including Assistant Clinical Project Manager, Clinical Project Manager, Strategic Relationship Director, and Business Development Director. Previously, Eric worked at Bracket (formerly UBC) as a Project Manager, Senior Project Manager, and Account Manager on key accounts for IRT. Eric played an integral role in developing a drug pooling model that was implemented for four protocols. He authored a chapter in the book, "Medical Imaging in Clinical Trials," focused on best practices for evaluating and selecting an imaging core lab consistent with Good Clinical Practice and regulatory compliance. As a member of the Metrics Champion Consortium (MCC), Eric contributed to the development of the Medical Imaging version 2.0 MCC Metrics.